← Leaderboards
Markus Schober
New York University School Of Medicine
$8,962,767
Attributed
$10,886,839
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,886,839 · 7
By mechanism
R01$9,723,290 · 5
R00$983,549 · 1
K99$180,000 · 1
Top collaborators
- Eva Hernando4 shared
- Meenhard Herlyn3 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Eva Hernando$15,270,218
- Kwok Kin Wong$31,472,345
- Itai Yanai$7,226,354
- Aristotelis Tsirigos$7,163,614
- Yuval Kluger$14,295,762
Others in their field
Top investigators on “Growth”
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$233,131,631
- Albert Lazzarini · California Institute Of Technology$170,110,000
- David H Reitze · University Of Florida$170,110,000
- Garret A Fitzgerald · University Of Pennsylvania$153,184,124
- David Heimbrook · Leidos Biomedical Research, Inc.$143,966,408
- Carol Nesel · Westat$116,355,411
Research focus
GrowthMalignant NeoplasmsTumorMolecularCellsPreventSkinMouse ModelSquamous Cell CarcinomaGenetic TranscriptionGene ExpressionNovel Therapeutic InterventionCarcinogenesisGenesTissuesProgramsMalignant Epithelial CellTranscription FactorRecurrenceSignal TransductionNeoplasm MetastasisAffectRegulationSelf-Renewal
Grant awards (28)
Dissecting Phenotype Switching in Early Stage Melanomas$625,456
R01 · FY2025 · CA · contact PI
Defining epigenetic regulators of tumor heterogeneity and metastasis in melanoma$514,655
R01 · FY2025 · CA
Roles and regulation of transcriptional reprogramming in squamous carcinogenesis$466,249
R01 · FY2025 · CA · contact PI
Post-translational SOX2 modification - a regulatory switch between self-renewal and differentiation in squamous cell carcinoma$435,586
R01 · FY2025 · CA · contact PI
Dissecting Phenotype Switching in Early Stage Melanomas$594,183
R01 · FY2024 · CA · contact PI
Defining epigenetic regulators of tumor heterogeneity and metastasis in melanoma$488,923
R01 · FY2024 · CA
Roles and regulation of transcriptional reprogramming in squamous carcinogenesis$468,096
R01 · FY2024 · CA · contact PI
Post-translational SOX2 modification - a regulatory switch between self-renewal and differentiation in squamous cell carcinoma$437,810
R01 · FY2024 · CA · contact PI
Dissecting Phenotype Switching in Early Stage Melanomas$612,946
R01 · FY2023 · CA · contact PI
Defining epigenetic regulators of tumor heterogeneity and metastasis in melanoma$504,361
R01 · FY2023 · CA
Roles and regulation of transcriptional reprogramming in squamous carcinogenesis$475,853
R01 · FY2023 · CA · contact PI
Post-translational SOX2 modification - a regulatory switch between self-renewal and differentiation in squamous cell carcinoma$454,783
R01 · FY2023 · CA · contact PI
Defining epigenetic regulators of tumor heterogeneity and metastasis in melanoma$507,620
R01 · FY2022 · CA
Roles and regulation of transcriptional reprogramming in squamous carcinogenesis$482,634
R01 · FY2022 · CA · contact PI
Post-translational SOX2 modification - a regulatory switch between self-renewal and differentiation in squamous cell carcinoma$441,695
R01 · FY2022 · CA · contact PI
Post-translational SOX2 modification - a regulatory switch between self-renewal and differentiation in squamous cell carcinoma$453,875
R01 · FY2021 · CA · contact PI
Regulation of cancer stem cell quiescence: Implications to tumor recurrence and t$351,713
R01 · FY2018 · CA · contact PI
Regulation of cancer stem cell quiescence: Implications to tumor recurrence and t$351,713
R01 · FY2017 · CA · contact PI
Regulation of cancer stem cell quiescence: Implications to tumor recurrence and t$351,713
R01 · FY2016 · CA · contact PI
Regulation of cancer stem cell quiescence: Implications to tumor recurrence and t$351,713
R01 · FY2015 · CA · contact PI
Regulation of cancer stem cell quiescence: Implications to tumor recurrence and t$351,713
R01 · FY2014 · CA · contact PI
Mechanisms of Homeostasis and Invasive Cell Migration in Skin Tumorigenesis$147,775
R00 · FY2014 · AR · contact PI
Mechanisms of Homeostasis and Invasive Cell Migration in Skin Tumorigenesis$236,549
R00 · FY2013 · AR · contact PI
Mechanisms of Homeostasis and Invasive Cell Migration in Skin Tumorigenesis$101,225
R00 · FY2013 · AR · contact PI
Mechanisms of Homeostasis and Invasive Cell Migration in Skin Tumorigenesis$249,000
R00 · FY2012 · AR · contact PI
Mechanisms of Homeostasis and Invasive Cell Migration in Skin Tumorigenesis$249,000
R00 · FY2011 · AR · contact PI
Mechanisms of homeostasis and invasive cell migration in skin tumorigenesis$90,000
K99 · FY2010 · AR · contact PI
Mechanisms of homeostasis and invasive cell migration in skin tumorigenesis$90,000
K99 · FY2009 · AR · contact PI